EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice

English version České info

The epithelial-mesenchymal transition (EMT) is an embryonic transdifferentiation process consisting of conversion of polarized epithelial cells to motile mesenchymal ones. EMT–inducing transcription factors are aberrantly expressed in multiple tumor types and are known to favor the metastatic dissemination process. Supporting oncogenic activity within primary lesions, the TWIST and ZEB proteins can prevent cells from undergoing oncogene-induced senescence and apoptosis by abolishing both p53- and RB-dependent pathways. Here we show that they also downregulate PP2A phosphatase activity and efficiently cooperate with an oncogenic version of H-RAS in malignant transformation of human mammary epithelial cells. Thus, by down-regulating crucial tumor suppressor functions, EMT inducers make cells particularly prone to malignant conversion. Importantly, by analyzing transformed cells generated in vitro and by characterizing novel transgenic mouse models, we further demonstrate that cooperation between an EMT inducer and an active form of RAS is sufficient to trigger transformation of mammary epithelial cells into malignant cells exhibiting all the characteristic features of claudin-low tumors, including low expression of tight and adherens junction genes, EMT traits, and stem cell–like characteristics. Claudin-low tumors are believed to be the most primitive breast malignancies, having arisen through transformation of an early epithelial precursor with inherent stemness properties and metaplastic features. Challenging this prevailing view, we propose that these aggressive tumors arise from cells committed to luminal differentiation, through a process driven by EMT inducers and combining malignant transformation and transdifferentiation.

Vyšlo v časopise: EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice. PLoS Genet 8(5): e32767. doi:10.1371/journal.pgen.1002723
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002723

Souhrn

Zdroje

1. YangJManiSADonaherJLRamaswamySItzyksonRA 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 927 939

2. ThieryJPAcloqueHHuangRYNietoMA 2009 Epithelial-mesenchymal transitions in development and disease. Cell 139 871 890

3. AcloqueHAdamsMSFishwickKBronner-FraserMNietoMA 2009 Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119 1438 1449

4. PeinadoHOlmedaDCanoA 2007 Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7 415 428

5. YangJWeinbergRA 2008 Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14 818 829

6. AnsieauSMorelAPHinkalGBastidJPuisieuxA 2010 TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29 3173 3184

7. MorelAPLievreMThomasCHinkalGAnsieauS 2008 Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3 e2888 doi:10.1371/journal.pone.0002888

8. ManiSAGuoWLiaoMJEatonENAyyananA 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 704 715

9. VesunaFLisokAKimbleBRamanV 2009 Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11 1318 1328

10. Valsesia-WittmannSMagdeleineMDupasquierSGarinEJallasAC 2004 Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell 6 625 630

11. AnsieauSBastidJDoreauAMorelAPBouchetBP 2008 Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14 79 89

12. OhashiSNatsuizakaMWongGSMichayliraCZGruganKD 2010 Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors. Cancer Res 70 4174 4184

13. PratAParkerJSKarginovaOFanCLivasyC 2010 Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12 R68

14. ConnerneyJAndreevaVLeshemYMercadoMADowellK 2008 Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol 318 323 334

15. ClarkGJDerCJ 1995 Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat 35 133 144

16. JacksonELWillisNMercerKBronsonRTCrowleyD 2001 Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15 3243 3248

17. WagnerKUWallRJSt-OngeLGrussPWynshaw-BorisA 1997 Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 25 4323 4330

18. WagnerKUMcAllisterKWardTDavisBWisemanR 2001 Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 10 545 553

19. RobinsonGWMcKnightRASmithGHHennighausenL 1995 Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121 2079 2090

20. MiyoshiKShillingfordJMLe ProvostFGounariFBronsonR 2002 Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A 99 219 224

21. NeveRMChinKFridlyandJYehJBaehnerFL 2006 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 515 527

22. HerschkowitzJISiminKWeigmanVJMikaelianIUsaryJ 2007 Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8 R76

23. TaubeJHHerschkowitzJIKomurovKZhouAYGuptaS 2010 Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107 15449 15454

24. HennessyBTGonzalez-AnguloAMStemke-HaleKGilcreaseMZKrishnamurthyS 2009 Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69 4116 4124

25. LimEVaillantFWuDForrestNCPalB 2009 Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15 907 913

26. KellerPJArendtLMSkibinskiALogvinenkoTKlebbaI 2011 Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A 109 2772 2777

27. HoeflichKPO'BrienCBoydZCavetGGuerreroS 2009 In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. Clin Cancer Res 15 4649 4664

28. HahnWCCounterCMLundbergASBeijersbergenRLBrooksMW 1999 Creation of human tumour cells with defined genetic elements. Nature 400 464 468

29. ElenbaasBSpirioLKoernerFFlemingMDZimonjicDB 2001 Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15 50 65

30. HahnWCDessainSKBrooksMWKingJEElenbaasB 2002 Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22 2111 2123

31. WongDJFosterSAGallowayDAReidBJ 1999 Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol 19 5642 5651

32. EichhornPJCreyghtonMPBernardsR 2009 Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 1795 1 15

33. ChenWPossematoRCampbellKTPlattnerCAPallasDC 2004 Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5 127 136

34. HanahanDWeinbergRA 2011 Hallmarks of cancer: the next generation. Cell 144 646 674

35. PallasDCShahrikLKMartinBLJaspersSMillerTB 1990 Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60 167 176

36. CampbellKSAugerKRHemmingsBARobertsTMPallasDC 1995 Identification of regions in polyomavirus middle T and small t antigens important for association with protein phosphatase 2A. J Virol 69 3721 3728

37. WalterGRuedigerR 2012 Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways. Cell Cycle 11 451 459

38. SeelingJMMillerJRGilRMoonRTWhiteR 1999 Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283 2089 2091

39. JanssensVGorisJ 2001 Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353 417 439

40. SpikeBTWahlGM 2011 p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome. Genes Cancer 2 404 419

41. TranPTShroffEHBurnsTFThiyagarajanSDasST 2012 Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis. PLoS Genet 8 e1002650 doi:10.1371/journal.pgen.1002650

42. Lopez-NovoaJMNietoMA 2009 Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1 303 314

43. DespratNSupattoWPouillePABeaurepaireEFargeE 2008 Tissue deformation modulates twist expression to determine anterior midgut differentiation in Drosophila embryos. Dev Cell 15 470 477

44. HoriguchiKShirakiharaTNakanoAImamuraTMiyazonoK 2009 Role of Ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem 284 245 253

45. ShinSDimitriCAYoonSODowdleWBlenisJ 2010 ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 38 114 127

46. HusemannYGeiglJBSchubertFMusianiPMeyerM 2008 Systemic spread is an early step in breast cancer. Cancer Cell 13 58 68

47. KlymkowskyMWSavagnerP 2009 Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 174 1588 1593

48. DamontePGreggJPBorowskyADKeisterBACardiffRD 2007 EMT tumorigenesis in the mouse mammary gland. Lab Invest 87 1218 1226

49. SantistebanMReimanJMAsieduMKBehrensMDNassarA 2009 Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69 2887 2895

50. ChafferCLBrueckmannIScheelCKaestliAJWigginsPA 2011 Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 108 7950 7955

51. ParanjapeANMandalTMukherjeeGKumarMVSenguptaK 2011 Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Oncogene 30 1896 1909

52. AsieduMKIngleJNBehrensMDRadiskyDCKnutsonKL 2011 TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res 71 4707 4719

53. SarrioDFranklinCKMackayAReis-FilhoJSIsackeCM 2012 Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells 30 292 303

54. PratAPerouCM 2011 Deconstructing the molecular portraits of breast cancer. Mol Oncol 5 5 23

55. van DeurzenCHLeeAHGillMSMenke-PluijmersMBJagerA 2011 Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation? J Pathol 224 434 437

56. HerschkowitzJIZhaoWZhangMUsaryJMurrowG 2012 Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A 109 2778 2783

57. ChangCJChaoCHXiaWYangJYXiongY 2011 p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13 317 323

58. KimTVeroneseAPichiorriFLeeTJJeonYJ 2011 p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 208 875 883

59. SiemensHJackstadtRHuntenSKallerMMenssenA 2011 miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10 4256 4271

60. ConnerneyJAndreevaVLeshemYMuentenerCMercadoMA 2006 Twist1 dimer selection regulates cranial suture patterning and fusion. Dev Dyn 235 1345 1357

61. BrummelkampTRBernardsRAgamiR 2002 A system for stable expression of short interfering RNAs in mammalian cells. Science 296 550 553